Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROSSINI 2: In-theatre interventions to reduce SSI in abdominal surgery
NCT03838575Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Mar 2019
- Primary completion
- May 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of chlorhexidine, gentamicin in surgical site infection (SSI), sponsored by University of Birmingham. Status: unknown.
02
Drugs
chlorhexidinegentamicin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT03838575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03838575.